Selected article for: "diagnosis time and high rate"
Author: Gabriel A Brat; Griffin M Weber; Nils Gehlenborg; Paul Avillach; Nathan P Palmer; Luca Chiovato; James Cimino; Lemuel R Waitman; Gilbert S Omenn; Alberto Malovini; Jason H Moore; Brett K Beaulieu-Jones; Valentina Tibollo; Shawn N Murphy; Sehi L'Yi; Mark S Keller; Riccardo Bellazzi; David A Hanauer; Arnaud Serret-Larmande; Alba Gutierrez-Sacristan; John J Holmes; Douglas S Bell; Kenneth D Mandl; Robert W Follett; Jeffrey G Klann; Douglas A Murad; Luigia Scudeller; Mauro Bucalo; Katie Kirchoff; Jean Craig; Jihad Obeid; Vianney Jouhet; Romain Griffier; Sebastien Cossin; Bertrand Moal; Lav P Patel; Antonio Bellasi; Hans U Prokosch; Detlef Kraska; Piotr Sliz; Amelia LM Tan; Kee Yuan Ngiam; Alberto Zambelli; Danielle L Mowery; Emily Schiver; Batsal Devkota; Robert L Bradford; Mohamad Daniar; Christel Daniel; Vincent Benoit; Romain Bey; Nicolas Paris; Patricia Serre; Nina Orlova; Julien Dubiel; Martin Hilka; Anne Sophie Jannot; Stephane Breant; Judith Leblanc; Nicolas Griffon; Anita Burgun; Melodie Bernaux; Arnaud Sandrin; Elisa Salamanca; Thomas Ganslandt; Tobias Gradinger; Julien Champ; Martin Boeker; Patricia Martel; Alexandre Gramfort; Olivier Grisel; Damien Leprovost; Thomas Moreau; Gael Varoquaux; Jill Jen Vie; Demian Wassermann; Arthur Mensch; Charlotte Caucheteux; Christian Haverkamp; Guillaume Lemaitre; Christian Haverkamp; Tianxi Cai; Isaac S Kohane
Title: International Electronic Health Record-Derived COVID-19 Clinical Course Profile: The 4CE Consortium
  • Document date: 2020_4_18
    • ID: 4y5279c5_56
    Snippet: Perhaps most importantly, our study did not show a unique laboratory signature at the country level at the time of diagnosis. Researchers around the world have been closely following the rapid spread of COVID-19 and its high mortality rate in certain countries. One possible explanation would be that patients who presented to hospitals in Italy did so at a much more advanced stage of disease. Our results did not support this idea. There was as muc.....
    Document: Perhaps most importantly, our study did not show a unique laboratory signature at the country level at the time of diagnosis. Researchers around the world have been closely following the rapid spread of COVID-19 and its high mortality rate in certain countries. One possible explanation would be that patients who presented to hospitals in Italy did so at a much more advanced stage of disease. Our results did not support this idea. There was as much in-hospital and between-hospital variation as between countries.

    Search related documents:
    Co phrase search for related documents
    • advanced stage and disease advanced stage: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
    • advanced stage and high mortality: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11
    • advanced stage and high mortality rate: 1, 2
    • advanced stage and rapid spread: 1, 2
    • certain country and country level: 1, 2
    • certain country and diagnosis time: 1
    • country level and diagnosis time: 1, 2, 3
    • country level and high mortality: 1, 2, 3, 4, 5
    • country level and rapid spread: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10
    • diagnosis time and disease advanced stage: 1, 2, 3
    • diagnosis time and high mortality: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
    • diagnosis time and high mortality rate: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14
    • diagnosis time and idea support: 1
    • diagnosis time and Italy hospital: 1, 2, 3, 4, 5
    • diagnosis time and laboratory signature: 1
    • diagnosis time and possible explanation: 1
    • diagnosis time and rapid spread: 1, 2, 3, 4, 5, 6, 7, 8, 9
    • disease advanced stage and high mortality: 1, 2, 3
    • disease advanced stage and rapid spread: 1